Stock ARYD ARYA SCIENCES ACQUISITION CORP IV
Add to a list
To use this feature you must be a member
Log inSign up

ARYA Sciences Acquisition Corp IV Share Price

Equities

ARYD

KYG316591083

Investment Holding Companies

Market Closed - Nasdaq
Other stock markets
 21:30:00 25/04/2024 BST 		5-day change 1st Jan Change
11.33 USD -0.18% Intraday chart for ARYA Sciences Acquisition Corp IV +0.18% +3.94%
03-29 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-08 ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV CI

Financials

Sales 2022 - Sales 2023 - Capitalization 86.41M 6.9B
Net income 2022 1M 79.8M Net income 2023 -2M -160M EV / Sales 2022 -
Net Debt 2022 0.03 2.31 Net Debt 2023 2.15 171.96 EV / Sales 2023 -
P/E ratio 2022
182 x
P/E ratio 2023
-50.1 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 43.79%
More Fundamentals * Assessed data

Chart ARYA Sciences Acquisition Corp IV

Dynamic Chart

Latest news about ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022 CI
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt CI
ARYA Sciences Acquisition Corp IV announced that it expects to receive $1.68 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.12 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news

Press releases ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition IV : Failure to Satisfy Listing Rule - Form 8-K PU
Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies PR
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K PU
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K PU
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K PU
More press releases

Quotes and Performance

1 day-0.18%
1 week+0.18%
Current month+0.89%
1 month+0.89%
3 months+2.81%
6 months+4.42%
Current year+3.94%
More quotes

Highs and lows

1 week
11.33
Extreme 11.329
11.39
1 month
11.27
Extreme 11.27
11.39
Current year
10.91
Extreme 10.91
11.39
1 year
10.41
Extreme 10.41
11.39
3 years
9.70
Extreme 9.7
11.39
5 years
9.70
Extreme 9.7
12.38
10 years
9.70
Extreme 9.7
12.38
More quotes

Managers and Directors - ARYA Sciences Acquisition Corp IV

Managers TitleAgeSince
Adam Stone FOU
 Founder 44 23/08/20
Konstantin Poukalov FOU
 Founder 40 31/12/20
Michael Altman FOU
 Founder 42 23/08/20
Members of the board TitleAgeSince
Leslie Trigg BRD
 Director/Board Member 53 24/02/21
Joseph Edelman FOU
 Founder 67 23/08/20
Michael Altman FOU
 Founder 42 23/08/20
More insiders

Quotes

Date Price Change Volume
25/04/24 11.33 -0.18% 15,615
24/04/24 11.35 0.00% 1,542

Delayed Quote Nasdaq, April 25, 2024 at 09:30 pm

More quotes

Company Profile

ARYA Sciences Acquisition Corp IV is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is focused on healthcare or healthcare related industries. The Company has no operations and has not generated revenues.
Sector
Investment Holding Companies
More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

1st Jan change Capi.
ARYA SCIENCES ACQUISITION CORP IV Stock ARYA Sciences Acquisition Corp IV
+3.94% 89.82M
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+137.37% 5.68B
SCREAMING EAGLE ACQUISITION CORP. Stock Screaming Eagle Acquisition Corp.
+1.89% 1.01B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.19% 982M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+25.27% 819M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.68% 663M
E7 GROUP Stock E7 Group
+1.80% 610M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
ALTC ACQUISITION CORP. Stock AltC Acquisition Corp.
+21.31% 552M
Shell Companies
  1. Stock Market
  2. Equities
  3. ARYD Stock